TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 3 | -1 | -2 | -1 | -17 | -24 | -26 | -12 |
| S | %wins | 67 | 33 | 67 | 100 | 100 | 100 | 78 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/4/13 17:09 | 8/30/13 | TROV | Trovagene, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Adams Thomas Phd | CA | D | S.m | -157 | 8.19 | 2 | -19 | -6 | 326 | D | 114 | 269 | 30 | 26 | -3 | -11 | -1 | -9 | -1 | 2 | -3 | -26 | -26 | -28 | |
11/1/12 20:22 | 10/31/12 | IRIS | Iris International Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Adams Thomas Phd | CA | O | CTO,Corp | S.d | -463 | 19.50 | 0 | -24 | -100 | 0 | M | ||||||||||||||
6/20/11 21:35 | 6/16/11 | IRIS | Iris International Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Adams Thomas Phd | CA | O | CTO,Corp | S | -184 | 9.21 | 1 | -20 | -8 | 238 | I | -17 | -14 | -6 | 4 | 3 | -2 | 6 | 3 | 3 | 1 | 9 | -7 | -3 | |
9/20/07 20:40 | 9/18/07 | IRIS | Iris International Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Adams Thomas Phd | CA | DO | CTO | S | -330 | 19.39 | 4 | -17 | -6 | 252 | D | 8 | 79 | 51 | 34 | 32 | 7 | 4 | 5 | -4 | -10 | -9 | -17 | -44 | -24 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |